a developer of biopharmaceuticals for novel cancer therapies
Industry Biotechnology
A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then ABOS could also see price increases.
Ticker / NAME | Correlation To SNDX | 1D Price Change % | ||
---|---|---|---|---|
SNDX | 100% | +1.14% | ||
ABOS - SNDX | 48% Loosely correlated | -0.84% | ||
RAPT - SNDX | 45% Loosely correlated | N/A | ||
BEAM - SNDX | 45% Loosely correlated | -3.16% | ||
VCYT - SNDX | 45% Loosely correlated | +0.13% | ||
ALEC - SNDX | 43% Loosely correlated | -5.58% | ||
More |